Entry |
|
Name |
Aleglitazar (USAN) |
Formula |
C24H23NO5S
|
Exact mass |
437.1297
|
Mol weight |
437.51
|
Structure |
|
Class |
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01732 Non-thiazolidinedione type PPAR agonist
|
Efficacy |
Antidiabetic, Peroxisome proliferator-activated receptor (PPAR) agonist |
Comment |
Treatment of type II diabetes
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01732 Non-thiazolidinedione type PPAR agonist
D08845 Aleglitazar
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C1 (PPARA)
D08845 Aleglitazar (USAN)
NR1C3 (PPARG)
D08845 Aleglitazar (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 31
1 C8y C 16.4500 -20.5800
2 C8y C 16.4500 -21.9800
3 C8x C 17.6624 -22.6800
4 C8x C 18.8749 -21.9800
5 C8y C 18.8749 -20.5800
6 C8y C 17.6624 -19.8800
7 O2a O 15.2376 -22.6800
8 C1b C 14.0421 -21.9896
9 C1b C 12.8547 -22.6751
10 C8y C 11.6635 -21.9871
11 C8y C 11.6563 -20.5804
12 O2x O 10.3189 -20.1529
13 C8y C 9.4990 -21.2926
14 N5x N 10.3297 -22.4246
15 C1a C 12.8066 -19.7355
16 C8y C 8.1201 -21.2990
17 C8x C 7.4062 -20.0756
18 C8x C 6.0062 -20.0822
19 C8x C 5.3119 -21.2979
20 C8x C 6.0258 -22.5212
21 C8x C 7.4258 -22.5146
22 S2x S 17.3714 -18.5106
23 C8x C 15.9790 -18.3642
24 C8x C 15.4096 -19.6432
25 C1b C 20.1060 -19.8690
26 C1c C 21.3112 -20.5647
27 C6a C 22.4935 -19.8819
28 O6a O 23.6875 -20.5712
29 O6a O 22.4935 -18.4802
30 O2a O 21.3116 -21.9796
31 C1a C 22.5005 -22.6659
BOND 34
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 1
14 13 14 2
15 10 14 1
16 11 15 1
17 13 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 20 21 2
23 16 21 1
24 6 22 1
25 22 23 1
26 23 24 2
27 1 24 1
28 5 25 1
29 25 26 1
30 26 27 1
31 27 28 1
32 27 29 2
33 26 30 1 #Up
34 30 31 1
|